GPLB

What one share of Green Planet Bioengineering Co. holds

Biological Products, (No Diagnostic Substances)

Green Planet Bioengineering Co., Ltd. (“Green Planet” or “Company”) operates as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation.

Green Planet Bioengineering Co.’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2019-09-30.

Per-share figures
Profit−$0.00
Cash and investments$0.00
Book value−$0.01

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2010—$0.04———−$0.01
2011—−$0.00———−$0.01
2012—−$0.00———−$0.00
2013—−$0.00———−$0.00
2014—−$0.00———−$0.01
2015—−$0.00———−$0.01
2016—−$0.00———−$0.01
2017—−$0.00———−$0.01
2018—−$0.00———−$0.01
2019—−$0.00———−$0.01
2020—−$0.00———−$0.02
2021—−$0.00———−$0.02
2023—−$0.00———−$0.02
2024—−$0.00———−$0.02
2025—−$0.00———−$0.03

Common questions about Green Planet Bioengineering Co.

How much does one share of Green Planet Bioengineering Co. earn?

Over the last 12 months, Green Planet Bioengineering Co. lost $0.00 for each share.

Does Green Planet Bioengineering Co. pay a dividend?

Green Planet Bioengineering Co. didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Green Planet Bioengineering Co.’s book value per share?

Green Planet Bioengineering Co.’s book value is negative (−$0.01 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of September 30, 2019.

How much cash and debt does each share of Green Planet Bioengineering Co. have?

Each share of Green Planet Bioengineering Co. has $0.00 of cash and investments, as of September 30, 2019.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.